Edwards Lifesciences (EW) vs Masco (MAS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Edwards Lifesciences (EW) has outperformed Masco (MAS) over the past year, gaining 11.8% versus a gain of 0.5%. Over five years, MAS leads with a +16.2% price change compared with -23.5% for EW. Edwards Lifesciences is the larger company by market cap ($49.44 billion vs $13.58 billion), about 3.6 times the size.
On valuation, Masco trades at a lower forward P/E (14.8x vs 25.4x for Edwards Lifesciences). Masco pays a dividend yielding 1.83%, while Edwards Lifesciences does not currently pay one. Edwards Lifesciences converts more of its revenue into profit, with a net margin of 17.7% versus 10.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | MAS |
|---|---|---|
| Share price | $85.78 | $68.87 |
| Market cap | $49.44B | $13.58B |
| 1-day change | -0.81% | -1.52% |
| YTD return | +0.62% | +8.53% |
| 1-year return | +11.81% | +0.50% |
| 5-year return | -23.52% | +16.20% |
| P/E ratio (TTM) | 51.06 | 15.87 |
| Forward P/E | 25.40 | 14.79 |
| EPS (TTM) | $1.68 | $4.34 |
| Dividend yield | 0.00% | 1.83% |
| Annual dividend | $0.00 | $1.26 |
| Revenue (latest FY) | $6.07B | $7.56B |
| Revenue growth (YoY) | +11.55% | -3.40% |
| Net income (latest FY) | $1.07B | $810.00M |
| Gross margin | 78.01% | 35.43% |
| Operating margin | 20.84% | 16.50% |
| Net margin | 17.69% | 10.71% |
| 52-week high | $96.29 | $83.64 |
| 52-week low | $72.30 | $58.16 |
| Distance from 52-week high | -10.91% | -17.66% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +18.86% | +16.23% |
| Average volume | 3.82M | 2.37M |
| Shares outstanding | 576.40M | 197.19M |
| Employees | 16,000 | 18,000 |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Edwards Lifesciences is about 3.6 times larger than Masco by market value ($49.44B vs $13.58B).
- EW has outperformed MAS by 11.3 percentage points over the past year.
- Edwards Lifesciences trades at a higher earnings multiple (51.1x vs 15.9x trailing P/E).
- Masco offers a meaningfully higher dividend yield (1.83% vs 0.00%).
- Edwards Lifesciences is more profitable, keeping 17.7 cents of every revenue dollar as net income versus 10.7 cents for Masco.
- Edwards Lifesciences grew revenue faster in its latest fiscal year (+11.55% vs -3.40%).
- The two companies sit in different sectors: Edwards Lifesciences in Health Care and Masco in Industrials.
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Health Care · Industrial Specialties · 16,000 employees
About Masco
MAS stock →Masco Corporation provides home improvement and building products in North America, Europe, and internationally. The company's Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bath hardware and accessories, bathing units, shower bases and enclosures, shower drains, steam shower systems, water filtration systems, and sinks and kitchen accessories; acrylic tubs, bath and shower enclosures, and shower bases and trays; spas, exercise pools, and aquatic fitness systems and saunas; brass, copper, and composite plumbing system component and other non-decorative plumbing products; water products; and thermoplastic products, extruded plastic profiles, and specialized fabrication products, as well as PEX tubing products.
Industrials · Industrial Specialties · 18,000 employees
EW vs MAS FAQ
Which is bigger, Edwards Lifesciences or Masco?
Edwards Lifesciences (EW) is larger, with a market capitalization of $49.44B compared with $13.58B for Masco (MAS).
Which stock has performed better over the past year, EW or MAS?
EW returned +11.81% over the past 12 months, compared with +0.50% for MAS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or MAS?
MAS has the lower trailing P/E at 15.9, versus 51.1 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or Masco?
Masco pays a dividend yielding 1.83%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and Masco in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.